Brief: Arterra Bioscience Selling Shareholders Complete Sale Of 23.3% Of Capital Share Via ABB For About EUR 2.8 Mln
April 6 (Reuters) - Arterra Bioscience SpA ABIS.MI :
* SAID ON WEDNESDAY SELLING SHAREHOLDERS ISAGRO SPA, MAARTEN
CHRISPEELS HAD COMPLETED SALE OF TOTAL OF 1,551,000 ARTERRA
BIOSCIENCE ORDINARY SHARES, EQUAL TO 23.3% OF COMPANY'S SHARE
CAPITAL, VIA ACCELLERATED BOOKBUILDING PROCEDURE
* PRICE/SHARE OF EUR 1.83, FOR A TOTAL VALUE OF ABOUT EURO
2.8 MLN
* AS A RESULT OF ACCELLERATED BOOKBUILDING PROCEDURE, FREE
FLOAT
RISES TO 49.5% OF SHARE CAPITAL
Further company coverage: ABIS.MI
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Arterra Bioscience SpA
See all newsBrief: Arterra Bioscience - Q1 Revenue EUR 1.6 Million
Brief: Arterra Bioscience Re-Food Project Approved For Financing, Granted Non-Repayable Contribution Of Around EUR 0.5 Mln
Brief: Arterra Bioscience FY Net Profit EUR 2.0 Mln
Brief: Arterra Bioscience FY Revenue At EUR 4.6 Mln
Brief: Arterra Bioscience Shareholder Maria Gabriella Colucci Sells 466,500 Shares At EUR 3.20/SHR To Smart Capital